Generation of an induced pluripotent stem cell line (SHCDNi003-A) from a one-year-old Chinese Han infant with Allan-Herndon-Dudley syndrome

Stem Cell Res. 2020 Jul:46:101872. doi: 10.1016/j.scr.2020.101872. Epub 2020 Jun 6.

Abstract

Allan-Herndon-Dudley syndrome (AHDS) is a rare, X-chromosome-linked inherited disorder that affects brain development and is caused by a mutation in SLC16A2. Herein, we generated an induced pluripotent stem cell (iPSC) line from the peripheral blood mononuclear cells of a one-year-old male infant with AHDS using Sendai-virus-mediated reprogramming. These iPSCs exhibited stable amplification, expressed pluripotent markers, and differentiated spontaneously into three germ layers in vitro. Additionally, this iPSC line was found to maintain a normal karyotype and retain the pathogenic mutation in SLC16A2, facilitating the study of disease mechanisms and development of new therapies of AHDS.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • China
  • Humans
  • Induced Pluripotent Stem Cells*
  • Infant
  • Leukocytes, Mononuclear
  • Male
  • Mental Retardation, X-Linked
  • Monocarboxylic Acid Transporters
  • Muscle Hypotonia
  • Muscular Atrophy
  • Symporters*

Substances

  • Monocarboxylic Acid Transporters
  • SLC16A2 protein, human
  • Symporters

Supplementary concepts

  • Allan-Herndon-Dudley syndrome